SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007809
Filing Date
2023-11-09
Accepted
2023-11-09 16:31:07
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2023 phio_i10q-093023.htm   iXBRL 10-Q 540114
2 2020 PHIO PHARMACEUTICALS CORP. LONG TERM INCENTIVE PLAN, AS AMENDED AND RESTATE phio_ex1001.htm EX-10.1 153670
3 FORM OF NONQUALIFIED STOCK OPTION AWARD UNDER THE COMPANY'S 2020 LONG TERM INCEN phio_ex1002.htm EX-10.2 44523
4 CERTIFICATION phio_ex3101.htm EX-31.1 10378
5 CERTIFICATION phio_ex3201.htm EX-32.1 4006
  Complete submission text file 0001683168-23-007809.txt   3259302

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE phio-20230930.xsd EX-101.SCH 26640
7 XBRL CALCULATION FILE phio-20230930_cal.xml EX-101.CAL 35435
8 XBRL DEFINITION FILE phio-20230930_def.xml EX-101.DEF 101915
9 XBRL LABEL FILE phio-20230930_lab.xml EX-101.LAB 225263
10 XBRL PRESENTATION FILE phio-20230930_pre.xml EX-101.PRE 181297
46 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-093023_htm.xml XML 354619
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 231393104
SIC: 2834 Pharmaceutical Preparations